M&A Deal Summary

Bora Pharmaceutical Acquires Pyros Pharmaceuticals

On October 25, 2024, Bora Pharmaceutical acquired life science company Pyros Pharmaceuticals

Acquisition Highlights
  • This is Bora Pharmaceutical’s 2nd transaction in the Life Science sector.
  • This is Bora Pharmaceutical’s 2nd transaction in the United States.
  • This is Bora Pharmaceutical’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2024-10-25
Target Pyros Pharmaceuticals
Sector Life Science
Buyer(s) Bora Pharmaceutical
Deal Type Add-on Acquisition
Advisor(s) Piper Sandler & Co. (Financial)
Cooley (Legal)

Target

Pyros Pharmaceuticals

Parsippany, New Jersey, United States
Pyros Pharmaceuticals is a specialty pharmaceutical company developing treatments for rare diseases. Pyros Pharmaceuticals was founded in 2017 and is based in Parsippany, New Jersey.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bora Pharmaceutical

Taipei, Taiwan
Category Company
Founded 2007
Sector Life Science
DESCRIPTION

Bora Pharmaceutical is focused on developing and manufacturing branded, generic, and over-the-counter (OTC) healthcare and pharmaceutical products for patients around the globe. Bora Pharmaceutical was founded in 2007 and is based in Taipei, Taiwan.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 2 of 2
Year (2024) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-17 Upsher-Smith Laboratories

Maple Grove, Minnesota, United States

Upsher-Smith Laboratories is a pharmaceutical company, that delivers quality therapies and solutions that measurably improve individuals’ lives. Upsher-Smith Laboratories is based in Maple Grove, Minnesota.

Buy -
Mergr

Product

Company

Legal